[go: up one dir, main page]

IT1303693B1 - Composizioni a rilascio controllato di metamizolo. - Google Patents

Composizioni a rilascio controllato di metamizolo.

Info

Publication number
IT1303693B1
IT1303693B1 IT1998MI002365A ITMI982365A IT1303693B1 IT 1303693 B1 IT1303693 B1 IT 1303693B1 IT 1998MI002365 A IT1998MI002365 A IT 1998MI002365A IT MI982365 A ITMI982365 A IT MI982365A IT 1303693 B1 IT1303693 B1 IT 1303693B1
Authority
IT
Italy
Prior art keywords
metamizole
controlled release
release compositions
compositions
controlled
Prior art date
Application number
IT1998MI002365A
Other languages
English (en)
Inventor
Mauro Valenti
Flavio Fabiani
Original Assignee
Formenti Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Formenti Farmaceutici Spa filed Critical Formenti Farmaceutici Spa
Priority to IT1998MI002365A priority Critical patent/IT1303693B1/it
Priority to AU11550/00A priority patent/AU1155000A/en
Priority to PCT/EP1999/008120 priority patent/WO2000025750A1/en
Priority to ARP990105435A priority patent/AR020998A1/es
Priority to CO99068639A priority patent/CO5160319A1/es
Priority to PE1999001101A priority patent/PE20001231A1/es
Publication of ITMI982365A1 publication Critical patent/ITMI982365A1/it
Application granted granted Critical
Publication of IT1303693B1 publication Critical patent/IT1303693B1/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
IT1998MI002365A 1998-11-03 1998-11-03 Composizioni a rilascio controllato di metamizolo. IT1303693B1 (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT1998MI002365A IT1303693B1 (it) 1998-11-03 1998-11-03 Composizioni a rilascio controllato di metamizolo.
AU11550/00A AU1155000A (en) 1998-11-03 1999-10-27 Controlled-release formulations of metamizole
PCT/EP1999/008120 WO2000025750A1 (en) 1998-11-03 1999-10-27 Controlled-release formulations of metamizole
ARP990105435A AR020998A1 (es) 1998-11-03 1999-10-28 Formulaciones de liberacion controlada de metamizol
CO99068639A CO5160319A1 (es) 1998-11-03 1999-10-29 Formulaciones de liberacion controlada de metamizol
PE1999001101A PE20001231A1 (es) 1998-11-03 1999-11-03 Formulaciones de liberacion controlada de metamizol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998MI002365A IT1303693B1 (it) 1998-11-03 1998-11-03 Composizioni a rilascio controllato di metamizolo.

Publications (2)

Publication Number Publication Date
ITMI982365A1 ITMI982365A1 (it) 2000-05-03
IT1303693B1 true IT1303693B1 (it) 2001-02-23

Family

ID=11380995

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1998MI002365A IT1303693B1 (it) 1998-11-03 1998-11-03 Composizioni a rilascio controllato di metamizolo.

Country Status (6)

Country Link
AR (1) AR020998A1 (it)
AU (1) AU1155000A (it)
CO (1) CO5160319A1 (it)
IT (1) IT1303693B1 (it)
PE (1) PE20001231A1 (it)
WO (1) WO2000025750A1 (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19920415A1 (de) * 1999-05-04 2000-11-09 Hexal Ag Metamizol enthaltende, kontrolliert freisetzende pharmazeutische Zusammensetzung
DE102008022520A1 (de) * 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
US10682337B2 (en) * 2015-03-03 2020-06-16 Kindred Biosciences, Inc. Compositions and methods for treatment and prevention of pyrexia in horses
WO2018087109A1 (de) 2016-11-08 2018-05-17 Grünenthal GmbH Multipartikuläre arzneiform mit kontrollierter freisetzung von metamizol

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0971743B1 (de) * 1997-04-18 2006-07-12 Fritz Stanislaus Stabilisiertes arzneimittel enthaltend cysteinylderivate

Also Published As

Publication number Publication date
ITMI982365A1 (it) 2000-05-03
WO2000025750A1 (en) 2000-05-11
AU1155000A (en) 2000-05-22
AR020998A1 (es) 2002-06-05
CO5160319A1 (es) 2002-05-30
PE20001231A1 (es) 2000-11-29

Similar Documents

Publication Publication Date Title
TR199800375A3 (tr) Selant kompozisyonlari.
PT1225874E (pt) Composicoes antivirais.
EP1081205A4 (en) RESIN COMPOSITIONS
CY2008020I1 (el) Παρατεταμενης απελευθepωσεως συνθεσεις ρανολαζινης
CU23049A3 (es) Dihidropirimidinas.
DE69942465D1 (de) Antiparasitäre Zusammensetzungen
IT1311977B1 (it) Composizioni idro-oleo repellenti.
DZ3212A1 (fr) Contacteur-disjoncteur.
BR9816029B1 (pt) composição detergente sólida.
ZA200001416B (en) Pesticidal compositions.
ATE296323T1 (de) Polyisocyanatzusammensetzungen
MA25379A1 (fr) Composes calcilythiques.
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
IT1309591B1 (it) Composizioni a rilascio controllato di betaistina.
TR199901017A3 (tr) Böcek ilaci terkibi.
MXPA03002117A (es) Composiciones fungicidas.
DE60104016D1 (de) Pestizide zusammensetzung
MA25359A1 (fr) Composition agrochimique.
ITTO20000385A0 (it) Composizione pesticida.
ITTO20000371A0 (it) Composizioni pesticide.
NO20014586L (no) Resorcinol sammensetninger
IT1303693B1 (it) Composizioni a rilascio controllato di metamizolo.
ZA200108893B (en) Fungicidal compositions.
ITTO20000386A0 (it) Composizione pesticida.
IT1307264B1 (it) Composizioni insetticide.